These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 2370646)

  • 1. Investigation of the beta 2-agonist properties of dilevalol: metabolic effects of intravenous infusion.
    Kendall MJ; Lewis HM; Haffner CA; Hughes BA
    J Hum Hypertens; 1990 Jun; 4 Suppl 2():65-8. PubMed ID: 2370646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pharmacodynamics of dilevalol.
    Riddell JG
    J Hum Hypertens; 1990 Jun; 4 Suppl 2():39-44. PubMed ID: 2370642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dilevalol: a dose-response study in normal volunteers.
    Walden RJ; Graham BR; Liu JB; Prichard BN
    J Hum Hypertens; 1990 Jun; 4 Suppl 2():69-75. PubMed ID: 2196371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and biological evaluation of dilevalol vasodilating properties in mild to moderate hypertension.
    Drici MD; Candito M; Ferrari E; Jacomet Y; Morand P; Lapalus P
    Int J Clin Pharmacol Ther Toxicol; 1991 Sep; 29(9):361-5. PubMed ID: 1937998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of the effects of beta-2 stimulation on free fatty acids in man.
    Kendall MJ; Clark NW; Haffner CA; Kong J; Hughes BA
    J Clin Pharm Ther; 1991 Feb; 16(1):31-40. PubMed ID: 2026667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downgrading of biochemical and cardiovascular responses to an intravenous infusion of terbutaline following chronic treatment with oral terbutaline.
    Smith SR; Kendall MJ
    Int J Clin Pharmacol Ther Toxicol; 1986 Jan; 24(1):1-3. PubMed ID: 3957482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of dilevalol on human atrial muscle.
    Brown MJ; Sanders L
    J Hum Hypertens; 1990 Jun; 4 Suppl 2():55-8. PubMed ID: 2370644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of dilevalol (R,R-labetalol) compared with nifedipine on heart rate, blood pressure and muscle blood flow at rest and on exercise in hypertensive patients.
    Walley T; Tsao Y; Scott A; Mackay E; Vandenburg M; Breckenridge A
    Br J Clin Pharmacol; 1993 Jun; 35(6):623-8. PubMed ID: 8329290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular and metabolic effects of terbutaline.
    Kendall MJ; Dean S; Bradley D; Gibson R; Worthington DJ
    J Clin Hosp Pharm; 1982 Mar; 7(1):31-6. PubMed ID: 7096576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in lymphocyte beta-adrenoceptor density after dilevalol oral treatment.
    Sbirrazzuoli V; Drici M; Garraffo R; Candito M; Gibelin P; Morand P; Lapalus P
    Drugs Exp Clin Res; 1989; 15(5):223-9. PubMed ID: 2551622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The dose dependency of the alpha-adrenoceptor antagonist and beta-adrenoceptor partial agonist activity of dilevalol and labetalol in man.
    Tham TC; McKaigue JP; Guy S; Shanks RG; Riddell JG
    Br J Clin Pharmacol; 1993 Sep; 36(3):251-6. PubMed ID: 9114912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Terbutaline-induced metabolic responses after propranolol and metoprolol].
    Chowanetz W; Schramm A
    Wien Klin Wochenschr; 1982 Dec; 94(24):658-62. PubMed ID: 6303001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the effects on renin release of beta adrenergic antagonists with differing properties.
    Weber MA; Stokes GS; Gain JM
    J Clin Invest; 1974 Dec; 54(6):1413-9. PubMed ID: 4154950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dilevalol in severe hypertension. A multicenter trial of bolus intravenous dosing.
    Wallin JD; Cook ME; Fletcher E; Holtzman JL; Winer N; Gavras H; Grim CE; Ramanathan KB; Vidt DG; Johnson BF
    Arch Intern Med; 1989 Dec; 149(12):2655-61. PubMed ID: 2688585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human cardiac beta1- or beta2-adrenergic receptor stimulation and the negative chronotropic effect of low-dose pirenzepine.
    Jakubetz J; Schmuck S; Wochatz G; Ruhland B; Poller U; Radke J; Brodde OE
    Clin Pharmacol Ther; 2000 May; 67(5):549-57. PubMed ID: 10824634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical pharmacology of dilevalol (I). Comparison of the pharmacokinetic and pharmacodynamic properties of dilevalol and labetalol after a single oral administration in healthy subjects.
    Fujimura A; Ohashi K; Tsuru M; Ebihara A; Kondo K
    J Clin Pharmacol; 1989 Jul; 29(7):635-42. PubMed ID: 2668352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of beta-blockade with beta-1-selectivity or intrinsic sympathomimetic activity on some metabolic responses to exercise.
    Yonga GO; Oyuga HW; Njeru EK
    East Afr Med J; 1993 Jul; 70(7):402-4. PubMed ID: 7904930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the antihypertensive dilevalol on large artery compliance in anesthetized dogs.
    Watkins RW; Sybertz EJ; Antonellis A; Pula K; Rivelli M
    J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S58-63. PubMed ID: 2454369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrinsic beta-sympathomimetic activity of dilevalol, R, R-isomer of labetalol.
    Matsunaga K; Nakamura K; Ueda M
    J Pharmacobiodyn; 1985 Sep; 8(9):785-7. PubMed ID: 2868089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of labetalol on plasma catecholamines at rest and during increased sympathetic activity.
    Carlsen JE; Trap-Jensen J; Svendsen TL; Nielsen PE; Rasmussen S; Christensen NJ
    Postgrad Med J; 1980; 56 Suppl 2():43-8. PubMed ID: 7433342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.